Understanding Differences in Enrollment Outcomes Among High-Risk Populations Recruited to a Phase IIb HIV Vaccine Trial
Journal of Acquired Immune Deficiency Syndromes - United States
doi 10.1097/qai.0b013e3181945eec
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2009
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)